You Can't Please Everyone
Consumers still aren't happy, but industry calls FDA's addition to PDUFA 'an important new step.'
Teaching an Old Market New Tricks
Novartis' upcoming anti-hypertension combo and campaign target noncompliance.
In Pharma We Trust?
Consumers say no, and they're watching which companies are naughty or nice.
